Ekaterina Vladimirovna Sofronova

Title: Ekaterina Vladimirovna Sofronova: Innovator in Biotechnology

Introduction

Ekaterina Vladimirovna Sofronova is a prominent inventor based in the Republic of Tatarstan, Russia. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 4 patents to her name, her work has the potential to impact various medical treatments.

Latest Patents

Sofronova's latest patents include an "Anti-IL-5RAlpha monoclonal antibody," which provides antibodies that specifically bind to IL-5Rα. This patent also encompasses DNA encoding the antibodies, corresponding expression vectors, and methods of production, as well as treatment methods utilizing these antibodies. Another notable patent is for a "Method for treatment of an IL-17A-mediated disease through antibody administration specific to human IL-17A." This patent describes monoclonal IgG-type antibodies that include variable domains represented by a combination of VHH-derivative with a variable domain of the light chain V. These antibodies are designed to have increased affinity and improved aggregation stability, with specific amino acid substitutions at positions 44 and 45.

Career Highlights

Throughout her career, Sofronova has worked with various organizations, including Biocad, a well-known biotechnology company. Her innovative work in antibody development has positioned her as a key figure in her field.

Collaborations

Sofronova has collaborated with notable professionals such as Timofey Aleksandrovich Nemankin and Yulia Sergeevna Chernykh, contributing to the advancement of biotechnology through teamwork and shared expertise.

Conclusion

Ekaterina Vladimirovna Sofronova is a distinguished inventor whose work in biotechnology, particularly in monoclonal antibodies, showcases her innovative spirit and dedication to advancing medical science. Her contributions are likely to have lasting effects on treatment methodologies in the healthcare sector.